|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.17 USD | +1.19% |
|
-0.53% | -3.20% |
| Market Cap | 3.48B 3.06B 2.85B 2.62B 4.91B 333B 4.99B 33.76B 13.22B 165B 13.07B 12.79B 570B | P/E 2026 * |
206x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.22B 2.82B 2.63B 2.42B 4.53B 307B 4.61B 31.2B 12.21B 152B 12.08B 11.82B 527B | EV / Sales 2026 * |
6.43x | EV / Sales 2027 * | 4.48x |
| Free-Float |
98.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Arcutis Biotherapeutics, Inc.
| 1 day | +1.28% | ||
| 1 week | -0.53% | ||
| Current month | +7.21% | ||
| 1 month | +5.04% | ||
| 3 months | +20.70% | ||
| 6 months | +10.45% | ||
| Current year | -3.20% |
| 1 week | 26.78 |  | 28.6 |
| 1 month | 25.25 | | 29.84 |
| Current year | 19.3 | | 30.75 |
| 1 year | 13.7 | | 31.77 |
| 3 years | 1.76 | | 31.77 |
| 5 years | 1.76 | | 31.77 |
| 10 years | 1.76 | | 40.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Todd Watanabe
CEO | Chief Executive Officer | 58 | 01/04/2017 |
| Corporate Officer/Principal | 71 | 03/12/2025 | |
Latha Vairavan
DFI | Director of Finance/CFO | - | 15/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Patrick Heron
CHM | Chairman | 55 | 01/12/2019 |
Todd Watanabe
BRD | Director/Board Member | 58 | 01/01/2016 |
Howard Welgus
BRD | Director/Board Member | 74 | 01/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/15/26 A | Free | Director | 38,811 | 0.0310% | ||
| 7/15/26 A | Other | Director | 187,500 | 0.1499% | ||
| 7/15/26 A | Fiscal year | Director | 12,922 | 0.0103% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.19% | -0.53% | +87.90% | +158.84% | 3.48B | |
| +3.13% | +1.96% | +23.23% | -7.73% | 67.88B | |
| +1.79% | +2.58% | +39.89% | +213.85% | 53.23B | |
| +0.26% | +54.90% | +54.90% | +54.90% | 48.71B | |
| +2.69% | -2.52% | -55.39% | -55.35% | 38.98B | |
| +1.10% | -0.57% | +56.25% | -23.84% | 29.55B | |
| +9.56% | +9.98% | +84.01% | +104.63% | 23.75B | |
| -0.13% | -6.99% | +63.64% | -53.24% | 22.07B | |
| +0.62% | -2.81% | +0.84% | +162.10% | 19.84B | |
| +0.60% | +0.39% | +65.65% | +126.60% | 16.57B | |
| Average | +2.10% | +0.47% | +42.09% | +68.08% | 32.4B | |
| Weighted average by Cap. | +2.20% | +1.30% | +32.98% | +55.07% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 500M 439M 409M 376M 705M 47.78B 717M 4.85B 1.9B 23.69B 1.88B 1.84B 81.86B | 647M 568M 529M 486M 912M 61.83B 928M 6.28B 2.46B 30.67B 2.43B 2.38B 106B |
| Net income | 18.54M 16.27M 15.15M 13.94M 26.13M 1.77B 26.58M 180M 70.37M 879M 69.61M 68.11M 3.04B | 136M 119M 111M 102M 191M 12.97B 195M 1.32B 515M 6.43B 510M 499M 22.22B |
| Net Debt | -265M -232M -216M -199M -373M -25.27B -379M -2.56B -1B -12.53B -993M -972M -43.31B | -580M -509M -474M -436M -817M -55.4B -831M -5.62B -2.2B -27.47B -2.18B -2.13B -94.92B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/07/26 | $28.14 | +1.06% | 278,011 |
| 27/07/26 | $27.84 | +1.79% | 1,199,084 |
| 24/07/26 | $27.35 | +0.07% | 819,355 |
| 23/07/26 | $27.33 | -2.04% | 1,031,412 |
| 22/07/26 | $27.90 | -1.27% | 802,453 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ARQT Stock
Select your edition
All financial news and data tailored to specific country editions
